BIOMARKER CEREBLON FOR DIAGNOSING HEPATOCELLULAR CARCINOMA, AND NOVEL MONOCLONAL ANTIBODY SPECIFIC THERETO
The present invention relates to a use of Cereblon (CRBN) as a biomarker for diagnosing hepatocellular carcinoma, and a novel monoclonal antibody specific to Cereblon. More specifically, the present invention relates to a composition for diagnosing hepatocellular carcinoma or predicting a prognosis...
Gespeichert in:
Hauptverfasser: | , |
---|---|
Format: | Patent |
Sprache: | eng ; fre ; kor |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!